Nonpurulent Cellulitis

Nonpurulent cellulitis is an acute infection of the dermis and subcutaneous tissue, usually driven by beta-hemolytic streptococci.^[1] It produces diffuse warmth, tenderness, edema, and poorly defined erythema or discoloration. The first therapeutic decision is not "which antibiotic?" but "is this truly cellulitis, and is it uncomplicated?" Bilateral lower-leg redness is far more likely to be a noninfectious mimic than bacterial cellulitis.

Nonpurulent cellulitis of the lower leg — diffuse warmth and poorly demarcated erythema without a drainable focus. (cbinrva, CC BY-SA 4.0, Wikimedia Commons)

• Acute unilateral warmth, tenderness, and swelling.
• Poorly demarcated erythema in light skin; in darker skin, inflammation may appear purple, brown, grey, or dusky, or may be better detected by warmth, edema, and tenderness than by colour change.^[2]
• May have lymphangitic streaking or regional lymphadenopathy.
• No drainable abscess or dominant purulent focus — this is what separates it from purulent cellulitis.

• Skin breaks, ulcers, wounds, fissures, or excoriations.
• Interdigital tinea pedis.
• Chronic edema/lymphedema and venous disease.
• Previous cellulitis.
• Diabetes, obesity, or immunosuppression.

Confirm infection

Document onset, borders, warmth, tenderness, edema, portal of entry, systemic symptoms, and comorbidities. Check interdigital spaces for tinea. Routine cultures are not useful in uncomplicated nonpurulent cellulitis because there is no accessible infected material to sample.^[3]

Actively exclude mimics

• Stop spread and systemic progression.
• Resolve pain, warmth, and edema.
• Prevent abscess, bacteremia, and recurrence.
• Correct the portal of entry — tinea pedis, chronic skin breakdown, ulcers.

• Elevate the affected limb above heart level when feasible.
• Use cool wet compresses for comfort.
• Mark the erythema border and record the time/date for objective follow-up.
• Treat tinea pedis, ulcers, eczema, and edema.
• For chronic lower-limb edema, initiate appropriate compression once acute pain/inflammation permits and contraindications are excluded — daily compression stocking use reduces recurrent cellulitis.^[4]

Pregnancy

Cephalexin, cefazolin, and other appropriate beta-lactams are generally preferred when the organism is susceptible. Clindamycin is an alternative when beta-lactams cannot be used.

Diabetes

Do not automatically treat simple cellulitis as a diabetic-foot infection. If ulceration, ischemia, neuropathy, or deep-foot involvement is present, move to a diabetic-foot-infection pathway instead.

Severe beta-lactam allergy

Confirm the allergy phenotype. Severe delayed reactions such as SJS/TEN require avoidance of implicated beta-lactams; use a non-beta-lactam regimen guided by severity and local susceptibility.

Reassess within 48-72 hours. The skin can look transiently more inflamed in the first 24-48 hours even when therapy is effective — judge the whole patient (pain, fever, spread rate, systemic status), not the erythema border alone. Improvement is demonstrated by stabilization of borders, less tenderness/warmth, and improved systemic symptoms.

1. Confirm diagnosis — reconsider stasis dermatitis, DVT, gout, and zoster.
2. Look for a hidden abscess, foreign body, or deeper focus.
3. Check adherence and antibiotic exposure.
4. Add MRSA-active therapy only if purulence or MRSA risk emerges.
5. Escalate to IV/hospital care if progression continues or systemic illness develops.

• Treating bilateral red legs as cellulitis without reconsidering stasis dermatitis.
• Adding MRSA coverage to every nonpurulent cellulitis case.
• Calling mild early inflammatory extension at 24 hours an automatic treatment failure.
• Ignoring tinea pedis and chronic edema as portals of entry.
• Missing necrotizing fasciitis because the erythema is not dramatic.

How to use this table: Doses are adult doses and require patient-specific confirmation (renal/hepatic function, weight, allergy history). Pediatric dosing is weight-based per the current product monograph unless stated. Drug pricing is intentionally omitted. Select any drug name to open its complete Pharmasist Drug Database page.

Oral therapy

Parenteral therapy (moderate/severe)